| 1 |
34382383 |
10.3324/haematol.2020.263251 |
2022 |
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma. |
PRDM1 |
| 2 |
35759728 |
10.1182/blood.2022015926 |
2022 |
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma. |
PRDM1 |
| 3 |
35794478 |
10.1038/s41586-022-04906-8 |
2022 |
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. |
PRDM1 |
| 4 |
32273478 |
10.3324/haematol.2020.251579 |
2021 |
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. |
PRDM1 |
| 5 |
32732362 |
10.3324/haematol.2020.254276 |
2021 |
Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. |
PRDM1 |
| 6 |
33199235 |
10.1016/j.intimp.2020.107137 |
2021 |
Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice. |
PRDM1 |
| 7 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
PRDM1 |
| 8 |
33629212 |
10.1007/s12032-021-01470-5 |
2021 |
Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. |
PRDM1 |
| 9 |
34236648 |
10.1007/978-1-0716-1669-7_20 |
2021 |
Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma. |
PRDM1 |
| 10 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
PRDM1 |
| 11 |
31980558 |
10.1136/jclinpath-2019-206282 |
2020 |
Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS. |
PRDM1 |
| 12 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
PRDM1 |
| 13 |
32127923 |
10.1177/1758835919900856 |
2020 |
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications. |
PRDM1 |
| 14 |
32533097 |
10.1038/s41388-020-1347-8 |
2020 |
The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma. |
PRDM1 |
| 15 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
PRDM1 |
| 16 |
32679859 |
10.3390/cancers12071912 |
2020 |
Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type. |
PRDM1 |
| 17 |
33017467 |
10.1182/bloodadvances.2020002049 |
2020 |
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1. |
PRDM1 |
| 18 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
PRDM1 |
| 19 |
33463110 |
10.18502/ijaai.v19i4.4118 |
2020 |
Increased Expression of B Lymphocyte Induced Maturation Protein 1 (BLIMP1) in Patients with Common Variable Immunodeficiency (CVID). |
PRDM1 |
| 20 |
30348636 |
10.1158/1078-0432.CCR-18-1153 |
2019 |
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. |
PRDM1 |
| 21 |
30935402 |
10.1186/s13045-019-0716-7 |
2019 |
Molecular pathogenic pathways in extranodal NK/T cell lymphoma. |
PRDM1 |
| 22 |
31024321 |
10.3389/fphar.2019.00367 |
2019 |
Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1. |
PRDM1 |
| 23 |
31378966 |
10.1002/ajh.25600 |
2019 |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. |
PRDM1 |
| 24 |
31806993 |
10.2147/OTT.S227122 |
2019 |
Genomic Alterations In Primary Cardiac Diffuse Large B Cell Lymphoma: A Case Report And Literature Review. |
PRDM1 |
| 25 |
29463002 |
10.3390/ijms19020601 |
2018 |
Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1. |
PRDM1 |
| 26 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
PRDM1 |
| 27 |
30274972 |
10.1158/2159-8290.CD-18-0657 |
2018 |
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis. |
PRDM1 |
| 28 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
PRDM1 |
| 29 |
28494239 |
10.1016/j.chom.2017.04.005 |
2017 |
CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors. |
PRDM1 |
| 30 |
28835384 |
10.1158/1535-7163.MCT-16-0840 |
2017 |
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL. |
PRDM1 |
| 31 |
29262531 |
10.18632/oncotarget.21986 |
2017 |
Mutational profile of primary breast diffuse large B-cell lymphoma. |
PRDM1 |
| 32 |
26111727 |
10.1111/nan.12259 |
2016 |
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas. |
PRDM1 |
| 33 |
27363279 |
NA |
2016 |
[Increased expressions of Blimp-1 and Bcl-6 in the deciduas of patients with unexplained recurrent spontaneous abortion]. |
PRDM1 |
| 34 |
27764808 |
10.18632/oncotarget.12680 |
2016 |
The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma. |
PRDM1 |
| 35 |
25991819 |
10.1158/1078-0432.CCR-14-2116 |
2015 |
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. |
PRDM1 |
| 36 |
26054109 |
NA |
2015 |
Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis. |
PRDM1 |
| 37 |
26289642 |
10.1182/blood-2015-02-626176 |
2015 |
The forkhead transcription factor FOXP1 represses human plasma cell differentiation. |
PRDM1 |
| 38 |
24030746 |
10.1038/modpathol.2013.156 |
2014 |
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma. |
PRDM1 |
| 39 |
24240734 |
10.1007/s00401-013-1202-x |
2014 |
Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. |
PRDM1 |
| 40 |
24487434 |
10.1038/nm.3442 |
2014 |
Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas. |
PRDM1 |
| 41 |
25232062 |
10.1182/blood-2014-07-590570 |
2014 |
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. |
PRDM1 |
| 42 |
23269792 |
10.1128/JVI.03003-12 |
2013 |
Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature. |
PRDM1 |
| 43 |
23355206 |
10.1309/AJCP0YGM8BLFYHJY |
2013 |
Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. |
PRDM1 |
| 44 |
23980171 |
10.1073/pnas.1309378110 |
2013 |
The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells. |
PRDM1 |
| 45 |
24009228 |
10.1182/blood-2013-05-498329 |
2013 |
Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. |
PRDM1 |
| 46 |
24200695 |
10.1172/JCI70626 |
2013 |
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. |
PRDM1 |
| 47 |
23027925 |
10.1084/jem.20112744 |
2012 |
Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production. |
PRDM1 |
| 48 |
20966935 |
10.1038/leu.2010.230 |
2011 |
Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas. |
PRDM1 |
| 49 |
21131593 |
10.1182/blood-2010-08-303123 |
2011 |
A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. |
PRDM1 |
| 50 |
21487109 |
10.1182/blood-2011-01-330795 |
2011 |
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. |
PRDM1 |
| 51 |
19047678 |
10.1182/blood-2008-10-184077 |
2009 |
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. |
PRDM1 |
| 52 |
19717648 |
10.1182/blood-2009-01-201111 |
2009 |
C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells. |
PRDM1 |
| 53 |
18235046 |
10.1182/blood-2007-08-108654 |
2008 |
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. |
PRDM1 |
| 54 |
18256039 |
10.1093/intimm/dxn005 |
2008 |
Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6. |
PRDM1 |
| 55 |
18354204 |
10.4049/jimmunol.180.7.4805 |
2008 |
STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. |
PRDM1 |
| 56 |
18983461 |
10.1111/j.1365-2559.2008.03144.x |
2008 |
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). |
PRDM1 |
| 57 |
16954503 |
10.1182/blood-2006-04-014977 |
2007 |
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. |
PRDM1 |
| 58 |
17545502 |
10.1182/blood-2007-01-069575 |
2007 |
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. |
PRDM1 |
| 59 |
17651861 |
10.1016/j.ejcb.2007.05.006 |
2007 |
IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. |
PRDM1 |
| 60 |
16585013 |
NA |
2006 |
PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. |
PRDM1 |
| 61 |
15231650 |
10.1158/0008-5472.CAN-03-3885 |
2004 |
High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. |
PRDM1 |
| 62 |
12165517 |
10.4049/jimmunol.169.4.1922 |
2002 |
Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. |
PRDM1 |
| 63 |
11067898 |
10.4049/jimmunol.165.10.5462 |
2000 |
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. |
PRDM1 |
Datasets
Models
